Table 6. Univariate and multivariate logistic regression analysis of metabolic syndrome components affecting ocular hypertension.
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| ORs (95% CI) | P value | ORs (95% CI) | P value | |
| Male | 1.07 (0.40–2.85) | 0.893 | 0.86 (0.36–2.06) | 0.741 |
| High blood pressure | 1.29 (0.44–3.75) | 0.644 | 0.98 (0.38–2.49) | 0.963 |
| High fasting glucose | 1.72 (0.79–3.75) | 0.169 | 1.18 (0.47–2.96) | 0.724 |
| High fasting insulin | 2.02 (0.80–5.10) | 0.136 | 1.13 (0.28–4.61) | 0.865 |
| High HOMA-IR | 2.44 (1.08–5.48) | 0.031* | 2.23 (0.88–5.70) | 0.092 |
| High BMI | 1.61 (0.64–4.05) | 0.306 | 0.57 (0.28–1.16) | 0.119 |
| Abdominal obesity | 2.38 (0.95–5.97) | 0.065 | 2.90 (1.35–6.23) | 0.007** |
| High triglyceride | 1.03 (0.36–2.89) | 0.962 | 0.76 (0.27–2.10) | 0.592 |
| Low HDL-C | 0.61 (0.22–1.65) | 0.326 | 0.41 (0.14–1.21) | 0.106 |
Metabolic syndrome components; high blood pressure (systolic ≥ 130 mmHg or diastolic ≥ 85 mmHg); high fasting glucose (≥ 100 mg/dL); high fasting insulin (≥ 13 μIU/mL); high HOMA-IR (≥ 2.34); high BMI (≥ 25 kg/m2); abdominal obesity (male ≥ 90 cm, female ≥ 85 cm); high triglycerides (≥ 150 mg/dL); low HDL-C (male < 40 mg/dL, female < 50 mg/dL).
OR = odds ratio, CI = confidence interval, HOMA-IR = homeostasis model assessment of insulin resistance, BMI = body mass index, HDL-C = high-density lipoprotein cholesterol.
*P < 0.05 and **P < 0.01 were considered statistically significant.